Markets:

Overview

News

Currencies

International

Treasuries

IQVIA Holdings, Inc. Common Stock (NY:IQV)

263.06 +4.85 (+1.88%)

Delayed Quote Updated: 1:17 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about IQVIA Holdings, Inc. Common Stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

19 20 Next >

Forecasting The Future: 8 Analyst Projections For IQVIA Hldgs ↗

May 03, 2024

Via Benzinga

IQV Stock Earnings: IQVIA Hldgs Beats EPS, Beats Revenue for Q1 2024 ↗

May 02, 2024

IQV stock results show that IQVIA Hldgs beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

IQVIA Reports First-Quarter 2024 Results

May 02, 2024

From IQVIA Holdings Inc.

Via Business Wire

Analysts Are Pounding the Table on These 3 Stocks: April 2024 ↗

May 01, 2024

From pharmaceutical testing to expansive integration expanding infrastructure, here are three stocks with analyst recommendations to buy.

Via InvestorPlace

IQVIA Celebrates Wendy Stewart and Susan Barnes, Winners of Healthcare Businesswoman's Association Luminary and Rising Star Awards

April 23, 2024

From IQVIA

Via Business Wire

Peering Into IQVIA Hldgs's Recent Short Interest ↗

March 29, 2024

Via Benzinga

Peering Into IQVIA Hldgs's Recent Short Interest ↗

March 13, 2024

Via Benzinga

How Is The Market Feeling About IQVIA Hldgs? ↗

February 15, 2024

Via Benzinga

IQVIA to Announce First-Quarter 2024 Results on May 2, 2024

April 15, 2024

From IQVIA Holdings Inc.

Via Business Wire

Salesforce & IQVIA Expand Partnership: Life Sciences Cloud Gets A Superpower Boost ↗

April 09, 2024

Salesforce shares rise after partnership with IQVIA to develop Life Sciences Cloud for customer engagement.

Via Benzinga

IQVIA and Salesforce Expand Global Partnership to Accelerate the Development of Life Sciences Cloud

April 08, 2024

From IQVIA

Via Business Wire

Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy? ↗

March 17, 2024

Madrigal's Rezdiffra will have the NASH market all to itself -- at least for a while.

Via The Motley Fool

Earnings Scheduled For February 14, 2024 ↗

February 14, 2024

Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is projected to report quarterly earnings at $1.65 per share on revenue of $24.62 billion.

Via Benzinga

Peeling Back The Layers: Exploring IQVIA Hldgs Through Analyst Insights ↗

February 13, 2024

Via Benzinga

Expert Ratings For IQVIA Hldgs ↗

January 25, 2024

Via Benzinga

IQVIA CFO Ron Bruehlman to Speak at Barclays Annual Global Healthcare Conference on March 13, 2024

March 06, 2024

From IQVIA Holdings Inc.

Via Business Wire

IQVIA Publishes its 2023 Environmental, Social and Governance Report

February 26, 2024

From IQVIA

Via Business Wire

Global Biopharma R&D Boasts Increased Funding, Productivity and Product Launches in 2023, says IQVIA Institute Report

February 23, 2024

From IQVIA

Via Business Wire

IQVIA CFO Ron Bruehlman to Speak at Citi’s Unplugged Medtech and Life Sciences Access Day on February 29, 2024

February 21, 2024

From IQVIA Holdings Inc.

Via Business Wire

(IQV) - Analyzing IQVIA Hldgs's Short Interest ↗

January 08, 2024

Via Benzinga

IQVIA Hldgs Stock: A Deep Dive Into Analyst Perspectives (11 Ratings) ↗

January 04, 2024

Via Benzinga

Stocks Rebound As Investor Focus Shifts To Earnings, Bitcoin Tops $1 Trillion Value: What's Driving Markets Wednesday? ↗

February 14, 2024

The U.S. stock market attempted a rebound following Tuesday’s declines, which were sparked by a higher-than-expected inflation report in January, as investors refocused on corporate earnings.

Via Benzinga

Topics Economy

Healthcare Analytics-Focused IQVIA Says 2023 Performance Solid Despite Challenging Macro Environment ↗

February 14, 2024

IQVIA beats Q4 2023 sales expectations, reporting $3.87 billion (3.5% Y/Y). Adjusted EPS of $2.84 exceeds guidance. IQV's 2023 performance and optimistic 2024 outlook.

Via Benzinga

Charles River Laboratories International Posts Upbeat Results, Joins Robinhood, Zillow, Tower Semiconductor And Other Big Stocks Moving Higher On Wednesday ↗

February 14, 2024

U.S. stocks were higher, with the Dow Jones index gaining more than 100 points on Wednesday.

Via Benzinga

Topics Stocks

IQVIA Reports Fourth-Quarter and Full-Year 2023 Results; Issues Full-Year 2024 Guidance

February 14, 2024

From IQVIA Holdings Inc.

Via Business Wire

IQVIA Named to Fortune® World's Most Admired Companies™ List, Ranked #1 in Its Sector for the Third Consecutive Year

February 06, 2024

From IQVIA

Via Business Wire

IQVIA to Announce Fourth-Quarter and Full-Year 2023 Results on February 14, 2024

January 24, 2024

From IQVIA Holdings Inc.

Via Business Wire

Global Medicine Spending to Reach $2.3 Trillion by 2028 as More Patients Get Access to Better Therapies, Says IQVIA Institute Report

January 17, 2024

From IQVIA

Via Business Wire

If You Can Only Buy One Biotech Stock in January, It Better Be One of These 3 Names ↗

January 10, 2024

Biotech is one of the areas of interest in the market today, adding a biotech stock could be huge play this month.

Via InvestorPlace

IQVIA's Bold Merger Move Blocked As FTC's Concerns Over Competition Take Center Stage ↗

January 02, 2024

IQVIA Holdings, Inc.'s (NYSE: IQV) attempt to acquire DeepIntent, a healthcare advertising firm, was reportedly thwarted as a U.S.

Via Benzinga

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

19 20 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.